Advanced Renal Cell Carcinoma Therapeutics Market Report

Global and Region Advanced Renal Cell Carcinoma Therapeutics Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：203
  • REPORT CODE：GMM907074
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Advanced Renal Cell Carcinoma Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Advanced Renal Cell Carcinoma Therapeuticsmarket, defines the market attractiveness level of Advanced Renal Cell Carcinoma Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Advanced Renal Cell Carcinoma Therapeutics industry, describes the types of Advanced Renal Cell Carcinoma Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Advanced Renal Cell Carcinoma Therapeutics market and the development prospects and opportunities of Advanced Renal Cell Carcinoma Therapeutics industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Advanced Renal Cell Carcinoma Therapeutics market in Chapter 13.

    By Player:

    • Bristol-Myers Squibb Company

    • Immatics Biotechnologies

    • Hoffmann-La Roche

    • Rexahn Pharmaceuticals

    • Merck

    • Bayer

    • Acceleron Pharma

    • Argos Therapeutics

    • Pfizer

    • Eisai

    • Novartis

    • AVEO Pharmaceuticals

    • Genentech

    • Ono Pharmaceutical

    • Exelixi

    By Type:

    • Radiation Therapy

    • Chemotherapy

    • Hormone Therapy

    • Investigational Therapy

    By End-User:

    • Hospitals

    • Cancer Research Institutes

    • Ambulatory Surgical Centers

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Advanced Renal Cell Carcinoma Therapeutics Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Advanced Renal Cell Carcinoma Therapeutics Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Advanced Renal Cell Carcinoma Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Advanced Renal Cell Carcinoma Therapeutics Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Advanced Renal Cell Carcinoma Therapeutics Market Analysis and Outlook to 2022

    • 7.1 Global Advanced Renal Cell Carcinoma Therapeutics Consumption (2017-2022)

    • 7.2 United States Advanced Renal Cell Carcinoma Therapeutics Consumption (2017-2022)

    • 7.3 Europe Advanced Renal Cell Carcinoma Therapeutics Consumption (2017-2022)

    • 7.4 China Advanced Renal Cell Carcinoma Therapeutics Consumption (2017-2022)

    • 7.5 Japan Advanced Renal Cell Carcinoma Therapeutics Consumption (2017-2022)

    • 7.6 India Advanced Renal Cell Carcinoma Therapeutics Consumption (2017-2022)

    • 7.7 South Korea Advanced Renal Cell Carcinoma Therapeutics Consumption (2017-2022)

    8 Region and Country-wise Advanced Renal Cell Carcinoma Therapeutics Market Analysis and Outlook to 2028

    • 8.1 Global Advanced Renal Cell Carcinoma Therapeutics Consumption Forecast (2022-2028)

    • 8.2 United States Advanced Renal Cell Carcinoma Therapeutics Consumption Forecast (2022-2028)

    • 8.3 Europe Advanced Renal Cell Carcinoma Therapeutics Consumption Forecast (2022-2028)

    • 8.4 China Advanced Renal Cell Carcinoma Therapeutics Consumption Forecast (2022-2028)

    • 8.5 Japan Advanced Renal Cell Carcinoma Therapeutics Consumption Forecast (2022-2028)

    • 8.6 India Advanced Renal Cell Carcinoma Therapeutics Consumption Forecast (2022-2028)

    • 8.7 South Korea Advanced Renal Cell Carcinoma Therapeutics Consumption Forecast (2022-2028)

    9 Global Advanced Renal Cell Carcinoma Therapeutics Market Outlook by Types and Applications to 2022

    • 9.1 Global Advanced Renal Cell Carcinoma Therapeutics Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Radiation Therapy Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Chemotherapy Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Hormone Therapy Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Investigational Therapy Consumption and Growth Rate (2017-2022)

    • 9.2 Global Advanced Renal Cell Carcinoma Therapeutics Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Cancer Research Institutes Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Advanced Renal Cell Carcinoma Therapeutics Market Outlook by Types and Applications to 2028

    • 10.1 Global Advanced Renal Cell Carcinoma Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Radiation Therapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Hormone Therapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Investigational Therapy Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Advanced Renal Cell Carcinoma Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Cancer Research Institutes Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Advanced Renal Cell Carcinoma Therapeutics Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Advanced Renal Cell Carcinoma Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Advanced Renal Cell Carcinoma Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Advanced Renal Cell Carcinoma Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Advanced Renal Cell Carcinoma Therapeutics Market Competitive Analysis

    • 14.1 Bristol-Myers Squibb Company

      • 14.1.1 Bristol-Myers Squibb Company Company Details

      • 14.1.2 Bristol-Myers Squibb Company Advanced Renal Cell Carcinoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Bristol-Myers Squibb Company Advanced Renal Cell Carcinoma Therapeutics Product and Service

    • 14.2 Immatics Biotechnologies

      • 14.2.1 Immatics Biotechnologies Company Details

      • 14.2.2 Immatics Biotechnologies Advanced Renal Cell Carcinoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Immatics Biotechnologies Advanced Renal Cell Carcinoma Therapeutics Product and Service

    • 14.3 Hoffmann-La Roche

      • 14.3.1 Hoffmann-La Roche Company Details

      • 14.3.2 Hoffmann-La Roche Advanced Renal Cell Carcinoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Hoffmann-La Roche Advanced Renal Cell Carcinoma Therapeutics Product and Service

    • 14.4 Rexahn Pharmaceuticals

      • 14.4.1 Rexahn Pharmaceuticals Company Details

      • 14.4.2 Rexahn Pharmaceuticals Advanced Renal Cell Carcinoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Rexahn Pharmaceuticals Advanced Renal Cell Carcinoma Therapeutics Product and Service

    • 14.5 Merck

      • 14.5.1 Merck Company Details

      • 14.5.2 Merck Advanced Renal Cell Carcinoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Merck Advanced Renal Cell Carcinoma Therapeutics Product and Service

    • 14.6 Bayer

      • 14.6.1 Bayer Company Details

      • 14.6.2 Bayer Advanced Renal Cell Carcinoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Bayer Advanced Renal Cell Carcinoma Therapeutics Product and Service

    • 14.7 Acceleron Pharma

      • 14.7.1 Acceleron Pharma Company Details

      • 14.7.2 Acceleron Pharma Advanced Renal Cell Carcinoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Acceleron Pharma Advanced Renal Cell Carcinoma Therapeutics Product and Service

    • 14.8 Argos Therapeutics

      • 14.8.1 Argos Therapeutics Company Details

      • 14.8.2 Argos Therapeutics Advanced Renal Cell Carcinoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Argos Therapeutics Advanced Renal Cell Carcinoma Therapeutics Product and Service

    • 14.9 Pfizer

      • 14.9.1 Pfizer Company Details

      • 14.9.2 Pfizer Advanced Renal Cell Carcinoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Pfizer Advanced Renal Cell Carcinoma Therapeutics Product and Service

    • 14.10 Eisai

      • 14.10.1 Eisai Company Details

      • 14.10.2 Eisai Advanced Renal Cell Carcinoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Eisai Advanced Renal Cell Carcinoma Therapeutics Product and Service

    • 14.11 Novartis

      • 14.11.1 Novartis Company Details

      • 14.11.2 Novartis Advanced Renal Cell Carcinoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Novartis Advanced Renal Cell Carcinoma Therapeutics Product and Service

    • 14.12 AVEO Pharmaceuticals

      • 14.12.1 AVEO Pharmaceuticals Company Details

      • 14.12.2 AVEO Pharmaceuticals Advanced Renal Cell Carcinoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 AVEO Pharmaceuticals Advanced Renal Cell Carcinoma Therapeutics Product and Service

    • 14.13 Genentech

      • 14.13.1 Genentech Company Details

      • 14.13.2 Genentech Advanced Renal Cell Carcinoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Genentech Advanced Renal Cell Carcinoma Therapeutics Product and Service

    • 14.14 Ono Pharmaceutical

      • 14.14.1 Ono Pharmaceutical Company Details

      • 14.14.2 Ono Pharmaceutical Advanced Renal Cell Carcinoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Ono Pharmaceutical Advanced Renal Cell Carcinoma Therapeutics Product and Service

    • 14.15 Exelixi

      • 14.15.1 Exelixi Company Details

      • 14.15.2 Exelixi Advanced Renal Cell Carcinoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Exelixi Advanced Renal Cell Carcinoma Therapeutics Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Advanced Renal Cell Carcinoma Therapeutics

    • Figure Advanced Renal Cell Carcinoma Therapeutics Picture

    • Table Global Advanced Renal Cell Carcinoma Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Advanced Renal Cell Carcinoma Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Advanced Renal Cell Carcinoma Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Advanced Renal Cell Carcinoma Therapeutics Consumption by Country (2017-2022)

    • Figure United States Advanced Renal Cell Carcinoma Therapeutics Consumption and Growth Rate (2017-2022)

    • Table Europe Advanced Renal Cell Carcinoma Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure China Advanced Renal Cell Carcinoma Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Japan Advanced Renal Cell Carcinoma Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure India Advanced Renal Cell Carcinoma Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure South Korea Advanced Renal Cell Carcinoma Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Global Advanced Renal Cell Carcinoma Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure United States Advanced Renal Cell Carcinoma Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Advanced Renal Cell Carcinoma Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Advanced Renal Cell Carcinoma Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Advanced Renal Cell Carcinoma Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Advanced Renal Cell Carcinoma Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Advanced Renal Cell Carcinoma Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Radiation Therapy Consumption and Growth Rate (2017-2022)

    • Figure Global Chemotherapy Consumption and Growth Rate (2017-2022)

    • Figure Global Hormone Therapy Consumption and Growth Rate (2017-2022)

    • Figure Global Investigational Therapy Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Cancer Research Institutes Consumption and Growth Rate (2017-2022)

    • Figure Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Radiation Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hormone Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Investigational Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cancer Research Institutes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Advanced Renal Cell Carcinoma Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Advanced Renal Cell Carcinoma Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    • Table Bristol-Myers Squibb Company (Foundation Year, Company Profile and etc.)

    • Table Bristol-Myers Squibb Company Advanced Renal Cell Carcinoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb Company Advanced Renal Cell Carcinoma Therapeutics Product and Service

    • Table Immatics Biotechnologies (Foundation Year, Company Profile and etc.)

    • Table Immatics Biotechnologies Advanced Renal Cell Carcinoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Immatics Biotechnologies Advanced Renal Cell Carcinoma Therapeutics Product and Service

    • Table Hoffmann-La Roche (Foundation Year, Company Profile and etc.)

    • Table Hoffmann-La Roche Advanced Renal Cell Carcinoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hoffmann-La Roche Advanced Renal Cell Carcinoma Therapeutics Product and Service

    • Table Rexahn Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Rexahn Pharmaceuticals Advanced Renal Cell Carcinoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Rexahn Pharmaceuticals Advanced Renal Cell Carcinoma Therapeutics Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Advanced Renal Cell Carcinoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Advanced Renal Cell Carcinoma Therapeutics Product and Service

    • Table Bayer (Foundation Year, Company Profile and etc.)

    • Table Bayer Advanced Renal Cell Carcinoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer Advanced Renal Cell Carcinoma Therapeutics Product and Service

    • Table Acceleron Pharma (Foundation Year, Company Profile and etc.)

    • Table Acceleron Pharma Advanced Renal Cell Carcinoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Acceleron Pharma Advanced Renal Cell Carcinoma Therapeutics Product and Service

    • Table Argos Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Argos Therapeutics Advanced Renal Cell Carcinoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Argos Therapeutics Advanced Renal Cell Carcinoma Therapeutics Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Advanced Renal Cell Carcinoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Advanced Renal Cell Carcinoma Therapeutics Product and Service

    • Table Eisai (Foundation Year, Company Profile and etc.)

    • Table Eisai Advanced Renal Cell Carcinoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eisai Advanced Renal Cell Carcinoma Therapeutics Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Advanced Renal Cell Carcinoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Advanced Renal Cell Carcinoma Therapeutics Product and Service

    • Table AVEO Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table AVEO Pharmaceuticals Advanced Renal Cell Carcinoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table AVEO Pharmaceuticals Advanced Renal Cell Carcinoma Therapeutics Product and Service

    • Table Genentech (Foundation Year, Company Profile and etc.)

    • Table Genentech Advanced Renal Cell Carcinoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genentech Advanced Renal Cell Carcinoma Therapeutics Product and Service

    • Table Ono Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Ono Pharmaceutical Advanced Renal Cell Carcinoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ono Pharmaceutical Advanced Renal Cell Carcinoma Therapeutics Product and Service

    • Table Exelixi (Foundation Year, Company Profile and etc.)

    • Table Exelixi Advanced Renal Cell Carcinoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Exelixi Advanced Renal Cell Carcinoma Therapeutics Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US